Table 3.

Co-medication status of patients in study

Characteristic	Hydromethylthionine 8 mg/day (n = 111)	Hydromethylthionine 200 mg/day (n = 109)	Total
Use of AChEI/memantine (Concomitant medication) n (%)
AChEI and/or memantine	25 (22.5%)	20 (18.3%)	45 (20.5%)
Both AChEI and memantine	7 (6.3%)	3 (2.8%)	10 (4.5%)
AChEI only	10 (9.0%)	7 (6.4%)	17 (7.7%)
Memantine only	8 (7.2%)	10 (9.2%)	18 (8.2%)
Use of Medical Food or Alternative Pharmacotherapy for Dementia n (%)
Yes	54 (48.6%)	49 (45.0%)	103 (46.8%)
No	57 (51.4%)	60 (55.0%)	117 (53.2%)
Use of Selective Serotonin Reuptake Inhibitor (SSRI) n (%)
Yes	30 (27.0%)	33 (30.3%)	63 (28.6%)
No	81 (73.0%)	76 (69.7%)	157 (71.4%)
Use of Drugs of Serotonergic Potential n (%)
Yes	49 (44.1%)	62 (56.9%)	111 (50.5%)
No	62 (55.9%)	47 (43.1%)	109 (49.5%)